Press Releases
Search
-
22 Jan 2014
Business Review for the year ended December 31, 2013
2013: solid 4.6% organic growth in sales At the top end of the target range announced early in the year Faster organic growth in North America and firmer business in Western Europe Sustained fast grow...
-
16 Jan 2014
bioMérieux finalizes acquisition of the U.S. company BioFire, specialized in molecular biology
Marcy l'Etoile, France, January 16, 2014 - bioMérieux, a world leader in the field of in vitro diagnostics, announces that it has finalized its acquisition of 100% ownership in BioFire Diagnostics Inc...
-
05 Dec 2013
bioMérieux is Moving Forward to a New Molecular Biology Workflow Solution for Reference or Centralized Laboratories
Marcy l'Étoile, France, December 5th, 2013 - bioMérieux, a world leader in the field of in vitro diagnostics, has announced that it is moving a new step forward to its comprehensive automation solutio...
-
28 Nov 2013
bioMérieux Announces Termination of its Collaboration with Biocartis in Molecular Biology
Marcy l'Etoile, France, November 28, 2013 - bioMérieux, a world leader in the field of in vitro diagnostics, and Biocartis have mutually agreed to end their collaboration to develop and commercialize ...
-
29 Oct 2013
bioMérieux launches the Parvovirus B19 R-gene® kit, a new ARGENE® test for the detection and quantification of the three Parvovirus B19 genotypes
Marcy l'Étoile, France, October 28, 2013 - bioMérieux, a world leader in the field of in vitro diagnostics, has announced the launch of the Parvovirus B19 R-gene® kit, a new CE-marked ARGENE® real-tim...
-
23 Oct 2013
Business Review for the Nine Months Ended September 30, 2013
Sales: 2013 objective confirmed Very good third quarter with sales up 7.4%* (5.7%* excluding R&D-related revenue) Robust organic growth of 3.9% over the first nine months (3.3% excluding R&D-related r...